NCT05963594

To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO

A Randomized, Double-Blind, Comparator-Controlled, Crossover Study to Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With Type 2 Diabetes (T2D) and in Otherwise Healthy Adults With Overweight or Obesity (HAO)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: Société des Produits Nestlé (SPN) · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The goal of this mechanistic, exploratory study is to compare the effectiveness of Oligomalt to Glucidex 40 after eating in adults with Type 2 Diabetes (T2D) and in otherwise healthy adults with overweight or obesity (HAO).

Detailed description

The main question it aims to answer is how consumption of Oligomalt, a slowly digestible carbohydrate, will reduce glucose and insulin spikes in adults with T2D and in HAO relative to Glucidex 40.

Conditions

• Dietary Supplement

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Oligomalt	The investigational product (Oligomalt) dissolved in 300 ml water will be consumed over approximately 10 minutes in the morning of the study visit after a fasting period of at least 10 hours.
DIETARY_SUPPLEMENT	maltodextrin	The investigational product (maltodextrin) dissolved in 300 ml water will be consumed over approximately 10 minutes in the morning of the study visit after a fasting period of at least 10 hours.

Timeline

• Start date: 2023-01-23
• Primary completion: 2023-03-28
• Completion: 2023-03-28
• First posted: 2023-07-27
• Last updated: 2023-07-27

Locations

1 site across 1 country: United States